全文获取类型
收费全文 | 3095篇 |
免费 | 356篇 |
国内免费 | 79篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 84篇 |
妇产科学 | 48篇 |
基础医学 | 304篇 |
口腔科学 | 52篇 |
临床医学 | 366篇 |
内科学 | 507篇 |
皮肤病学 | 35篇 |
神经病学 | 249篇 |
特种医学 | 156篇 |
外科学 | 533篇 |
综合类 | 121篇 |
一般理论 | 12篇 |
预防医学 | 244篇 |
眼科学 | 226篇 |
药学 | 310篇 |
1篇 | |
中国医学 | 2篇 |
肿瘤学 | 249篇 |
出版年
2021年 | 50篇 |
2020年 | 26篇 |
2019年 | 39篇 |
2018年 | 48篇 |
2017年 | 45篇 |
2016年 | 41篇 |
2015年 | 40篇 |
2014年 | 57篇 |
2013年 | 88篇 |
2012年 | 128篇 |
2011年 | 139篇 |
2010年 | 73篇 |
2009年 | 77篇 |
2008年 | 121篇 |
2007年 | 186篇 |
2006年 | 109篇 |
2005年 | 141篇 |
2004年 | 129篇 |
2003年 | 143篇 |
2002年 | 105篇 |
2001年 | 106篇 |
2000年 | 112篇 |
1999年 | 89篇 |
1998年 | 51篇 |
1997年 | 62篇 |
1996年 | 57篇 |
1995年 | 53篇 |
1994年 | 47篇 |
1993年 | 38篇 |
1992年 | 65篇 |
1991年 | 55篇 |
1990年 | 79篇 |
1989年 | 59篇 |
1988年 | 74篇 |
1987年 | 68篇 |
1986年 | 75篇 |
1985年 | 78篇 |
1984年 | 44篇 |
1983年 | 40篇 |
1982年 | 33篇 |
1981年 | 37篇 |
1980年 | 29篇 |
1979年 | 40篇 |
1978年 | 39篇 |
1977年 | 30篇 |
1976年 | 28篇 |
1975年 | 27篇 |
1973年 | 16篇 |
1972年 | 20篇 |
1971年 | 24篇 |
排序方式: 共有3530条查询结果,搜索用时 15 毫秒
61.
Evaluating the use of plerixafor in stem cell mobilisation – an economic analysis of the PHANTASTIC trial
下载免费PDF全文
![点击此处可从《Journal of clinical apheresis》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Antony P. Martin Sarah Richards Alan Haycox Rachel Houten Claire McLeod Barbara Braithwaite Jack O. Clark Joanne Bell Richard E. Clark 《Journal of clinical apheresis》2016,31(5):434-442
Plerixafor is an effective haematopoietic stem cell mobilising agent in candidates for autologous transplantation, including patients with myeloma and lymphoma. Here we compare 98 plerixafor recipients in the PHANTASTIC trial with 151 historic controls mobilised by conventional chemotherapy (each with granulocyte colony‐stimulating factor, G‐CSF). Seventy (71.4%) plerixafor‐mobilised patients achieved the composite primary endpoint of ≥4 × 106 CD34+ cells kg?1 in ≤2 aphereses and no clinically significant neutropenia, compared to 48 (31.8%) historic controls (P < 0.001), and this significant advantage was maintained in scenario analyses testing components of this composite endpoint. A patient‐level cost analysis was undertaken for 249 patients, which included the cost of remobilising patients where initial mobilisation had failed. Combined mean treatment cost for plerixafor mobilised patients was £12,679 compared with £11,694 for historical controls. However, plerixafor produces an average saving of £3,828 per lymphoma patient but average cost increase by £5,245 per myeloma patient. The present data demonstrate cost‐effectiveness for plerixafor as a first line mobilisation agent, certainly for lymphoma patients, where substantial resource savings and achievement of the primary endpoint are likely. J. Clin. Apheresis 31:434–442, 2016. © 2015 Wiley Periodicals, Inc. 相似文献
62.
63.
64.
We report a case of a massive mediastinal teratoma in an 18-year-old woman who presented with a short history of exertional dyspnoea. The tumor arose from the left lobe of the thymus and extended into the left pleural cavity, completely compressing the left lung and extensively shifting the mediastinum to the right. Measuring 23 cm x 17 cm x 9 cm and weighing 2005 g it is one of the largest anterior mediastinal teratomas reported. It was successfully treated by surgical resection, with a final pathological diagnosis of a grades 1-2 immature teratoma. 相似文献
65.
Mark TL Kranzler HR Poole VH Hagen CA McLeod C Crosse S 《The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions》2003,12(4):281-294
In 1994, naltrexone became the first medication approved by the Food and Drug Administration as an adjunct in alcoholism treatment in almost fifty years. Despite evidence of its efficacy, use of naltrexone is not widespread. Patient and physician focus groups were used to identify reasons naltrexone has not been prescribed more widely. Barriers to its widespread use include a lack of awareness, a lack of evidence of efficacy in practice, side effects, time for patient management, a reluctance to take medications, medication addiction concerns, Alcoholics Anonymous (AA) philosophy, and price. The study indicates that medications to treat alcoholism must overcome numerous barriers before becoming widely accepted. 相似文献
66.
Activation marker expression and apoptotic susceptibility of T-cell clones derived from CD34(+), young and SENIEUR donors 总被引:1,自引:0,他引:1
T-cell clones (TCC) derived from human peripheral blood lymphocytes of a young control, a healthy elderly (SENIEUR) donor, or from CD34(+) hematopoietic progenitor cells were utilised in this study to examine how in vivo and in vitro ageing affects T-cell apoptotic capability. The role of CD25, CD28 and the intracellular proteins, FLICE-inhibitory protein (FLIP), receptor-interacting protein (RIP) and caspase 3 were investigated. We observed an age-related decline in the expression of the IL-2 receptor alpha chain CD25, and absence of the co-stimulatory receptor CD28 on three of the four TCC studied. In young donor- and CD34 cell-derived TCC, but not in SENIEUR donor-derived TCC, we observed an age-related increase in susceptibility of the cells to mFas-L-induced apoptosis, which correlated with the age-related decrease of CD25 expression. Expression levels of full-length RIP and FLIP did not show any correlation to apoptotic susceptibility. However, expression levels of the cleaved form of RIP were greatly reduced in the SENIEUR donor-derived TCC, which together with a trend towards increased caspase 3 activity, could indicate an age-related alteration in utilisation of different apoptotic signalling pathways. 相似文献
67.
Harshfield GA Wilson ME McLeod K Hanevold C Kapuku GK Mackey L Gillis D Edmonds L 《Hypertension》2003,42(6):1082-1086
The purpose of this study was to determine if there are gender differences in stress-induced pressure natriuresis and to examine the effects of adiposity on these differences. The subjects were 151 boys and 141 girls 15 to 18 years of age who underwent a 5-hour stress protocol (2-hour prestress, 1-hour stress, 2-hour poststress) after being brought into similar levels of sodium balance. The gender-by-condition interaction was significant for systolic and diastolic blood pressure (P=0.001 for both), and the effect of condition was significant for sodium excretion (P=0.001). Systolic blood pressure was higher for boys throughout the protocol (P=0.001 for each) and correlated with body mass index at each condition (range in r=0.28 to 0.35; P<0.001 for each). Hemodynamically, in boys body mass index was correlated with cardiac output during stress (r=0.23; P=0.006), which was correlated with systolic blood pressure (r=0.21; P=0.01). With respect to natriuresis, body mass index was inversely correlated with sodium excretion during stress (r=-0.22; P=0.008) and positively correlated with angiotensin II in a subsample of boys (n=89: r=0.31; P=0.003). The inverse correlation between angiotensin II and sodium excretion during stress approached significance (r=-0.17; P<0.06). Similar results were not observed for girls. In conclusion, gender differences in stress-induced pressure natriuresis appear to be related to the influence of adiposity on both blood pressure and natriuresis. 相似文献
68.
69.
Dziennis S; Van Etten RA; Pahl HL; Morris DL; Rothstein TL; Blosch CM; Perlmutter RM; Tenen DG 《Blood》1995,85(2):319-329
CD11b is the alpha chain of the Mac-1 integrin and is preferentially expressed in myeloid cells (neutrophils, monocytes, and macrophages). We have previously shown that the CD11b promoter directs cell-type- specific expression in myeloid lines using transient transfection assays. To confirm that these promoter sequences contain the proper regulatory elements for correct myeloid expression of CD11b in vivo, we have used the -1.7-kb human CD11b promoter to direct reporter gene expression in transgenic mice. Stable founder lines were generated with two different reporter genes, a Thy 1.1 surface marker and the Escherichia coli lacZ (beta-galactosidase) gene. Analysis of founders generated with each reporter demonstrated that the CD11b promoter was capable of driving high levels of transgene expression in murine macrophages for the lifetime of the animals. Similar to the endogenous gene, transgene expression was preferentially found in mature monocytes, macrophages, and neutrophils and not in myeloid precursors. These experiments indicate that the -1.7 CD11b promoter contains the regulatory elements sufficient for high-level macrophage expression. This promoter should be useful for targeting heterologous gene expression to mature myeloid cells. 相似文献
70.